Romania Pharmaceuticals and Healthcare Report Q2 2012Business Monitor InternationalMarch 20, 2012 100 Pages - SKU: BMI3816816 |
- Executive Summary
- SWOT Analysis
- Romania Pharmaceuticals And Healthcare Industry SWOT
- Romania Political SWOT
- Romania Economic SWOT
- Romania Business Environment SWOT
- Pharmaceutical Risk/Reward Ratings
- Table: Emerging Europe – Regional Pharmaceutical Risk/Reward Ratings, Q212
- Rewards
- Risks
- Romania – Market Summary
- Regulatory Regime
- Intellectual Property Issues
- Corruption
- Reimbursement Regime
- Reimbursement Regime Developments
- Claw-back Tax
- Pricing Regime
- Industry Developments
- Epidemiology
- Healthcare Sector
- Possible Delays To Further Healthcare Reforms
- Approved Healthcare Reforms In Brief
- Drafted But Withdrawn Structural Healthcare Reforms
- Private Healthcare Services
- Payment Delays
- Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2008-2016
- Key Growth Factors – Industry
- Table: Healthcare Expenditure Indicators 2008-2016
- Table: Healthcare Governmental Indicators 2008-2016
- Table: Healthcare Private Indicators 2008-2016
- Macroeconomic Forecast Scenario
- Romania – Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2008-2016
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2008-2016
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2008-2016
- OTC Medicine Market Forecast
- Table – Romania OTC Medicine Sub-Sector Market
- Table: OTC Medicine Sales Indicators 2008-2016
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2008-2016
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2008-2016
- Key Risks to BMI’s Forecast Scenario
- Competitive Landscape
- Pharmaceutical Industry
- Pharmaceutical Company Activities
- Company Monitor
- Indigenous Companies
- Zentiva Romania
- Actavis Romania (Sindan)
- Terapia-Ranbaxy
- Antibiotice Iasi
- LaborMed Pharma
- Foreign Companies
- GlaxoSmithKline (Europharm)
- Roche
- Sanofi
- Novartis
- Pfizer
- Krka
- Merck & Co
- Country Snapshot: Romania Demographic Data
- Section 1: Population
- Section 2: Education and Healthcare
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market and Spending Power
- Table: Employment Indicators, 2001-2006
- Table: Consumer Expenditure, 2005-2010 (US$)
- Table: Average Annual Wages, 2006-2010
- Glossary
- BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceuticals Business Environment Ratings
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Facilities
- Hospitals & Clinics
- Healthcare
- Country Overviews
- Life Sciences
- Healthcare
- Pharmaceuticals
- Pharmaceuticals
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports
